Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9K Hold
8
﹤0.01% 318
2026
Q1
$2.81K Hold
8
﹤0.01% 321
2025
Q4
$2.62K Hold
8
﹤0.01% 301
2025
Q3
$2.26K Sell
8
-9
-53% -$2.61K ﹤0.01% 299
2025
Q2
$4.75K Buy
+17
New +$4.82K ﹤0.01% 243

Other funds holding AMGN

Swan Capital's AMGN Position: Q2 2026 in Review

Swan Capital held its Amgen (AMGN) position steady in Q2 2026 at 8 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

Swan Capital first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.75K in Q2 2025. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Swan Capital held 8 shares of Amgen worth $2.9K as of Q2 2026.
  • Swan Capital left its Amgen share count unchanged in Q2 2026.
  • Amgen made up ﹤0.01% of Swan Capital's portfolio in Q2 2026, its #318 holding.
  • Swan Capital first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • Swan Capital's Amgen position peaked at $4.75K in Q2 2025.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Swan Capital's 13F filing for Q2 2026, filed 13 Aug 2026.